Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Accounts Payables (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Accounts Payables for 8 consecutive years, with $917000.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 57.53% to $917000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $917000.0 through Dec 2025, down 57.53% year-over-year, with the annual reading at $917000.0 for FY2025, 57.53% down from the prior year.
  • Accounts Payables for Q4 2025 was $917000.0 at Whitehawk Therapeutics, down from $1.6 million in the prior quarter.
  • The five-year high for Accounts Payables was $6.5 million in Q1 2023, with the low at $458658.0 in Q1 2021.
  • Average Accounts Payables over 5 years is $3.2 million, with a median of $3.2 million recorded in 2024.
  • The sharpest move saw Accounts Payables crashed 75.06% in 2021, then soared 774.29% in 2022.
  • Over 5 years, Accounts Payables stood at $6.4 million in 2021, then tumbled by 45.35% to $3.5 million in 2022, then soared by 67.6% to $5.9 million in 2023, then tumbled by 63.39% to $2.2 million in 2024, then tumbled by 57.53% to $917000.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $917000.0, $1.6 million, and $3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.